Ian J. Majewski
The Royal Melbourne Hospital(AU)The University of Melbourne(AU)Walter and Eliza Hall Institute of Medical Research(AU)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Epigenetics and DNA Methylation, PARP inhibition in cancer therapy, Acute Myeloid Leukemia Research, Chronic Lymphocytic Leukemia Research
Most-Cited Works
- → The Pseudokinase MLKL Mediates Necroptosis via a Molecular Switch Mechanism(2013)1,195 cited
- → Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML(2020)633 cited
- → Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic Leukemia(2018)417 cited
- → Colorectal cancer intrinsic subtypes predict chemotherapy benefit, deficient mismatch repair and epithelial‐to‐mesenchymal transition(2013)350 cited
- → The BCL2 selective inhibitor venetoclax induces rapid onset apoptosis of CLL cells in patients via a TP53-independent mechanism(2016)324 cited
- → ChIP-seq analysis reveals distinct H3K27me3 profiles that correlate with transcriptional activity(2011)318 cited